Montreal, June 19, 2026 — McGill University’s DNA to RNA (D2R) initiative has announced two new international research projects aimed at accelerating personalized genomic medicine and RNA-based therapies. Funded through D2R’s International Partnerships Program (IPP), each project receives $600,000 and brings together leading institutions across North America, Europe, and Asia.